ArticleLeukemia2024

High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia.

Daisuke Tomizawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.